Latest Knowledge on the Role of Vitamin D in Hypertension
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24054679 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Niklas S Jensen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Aarhus University, Ole Worms Allé 4, 8000 Aarhus, Denmark. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension, Vitamin D, Bone Density Conservation Agents. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hypertension is the third leading cause of the global disease burden, and while populations live longer, adopt more sedentary lifestyles, and become less economically concerned, the prevalence of hypertension is expected to increase. Pathologically elevated blood pressure (BP) is the strongest risk factor for cardiovascular disease (CVD) and related disability, thus making it imperative to treat this disease. Effective standard pharmacological treatments, i.e., diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blocker (ARBs), beta-adrenergic receptor blockers (BARBs), and calcium channel blockers (CCBs), are available. Vitamin D (vitD) is known best for its role in bone and mineral homeostasis. Studies with vitamin D receptor (VDR) knockout mice show an increased renin–angiotensin–aldosterone system (RAAS) activity and increased hypertension, suggesting a key role for vitD as a potential antihypertensive agent. Similar studies in humans displayed ambiguous and mixed results. No direct antihypertensive effect was shown, nor a significant impact on the human RAAS. Interestingly, human studies supplementing vitD with other antihypertensive agents reported more promising results. VitD is considered a safe supplement, proposing its great potential as antihypertensive supplement. The aim of this review is to examine the current knowledge about vitD and its role in the treatment of hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedicine, Aarhus University, Ole Worms Allé 4, 8000 Aarhus, Denmark.
- Department of Microgravity and Translational Regenerative Medicine, University Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany.
- Research Group "Magdeburger Arbeitsgemeinschaft für Forschung unter Raumfahrt- und Schwerelosigkeitsbedingungen" (MARS), Otto von Guericke University, 39106 Magdeburg, Germany.
- The Saban Research Institute, Children's Hospital Los Angeles, University of Southern California, 4650 Sunset Blvd, Los Angeles, CA 90027, USA.
ORCID-Profile: Markus Wehland, Daniela Grimm
Zitieren
APA
Jensen, N. S., Wehland, M., Wise, P. M., & Grimm, D. (2023). Latest Knowledge on the Role of Vitamin D in Hypertension. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054679
Vancouver
Jensen NS, Wehland M, Wise PM, Grimm D. Latest Knowledge on the Role of Vitamin D in Hypertension. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054679
BibTeX
@article{Jensen2023,
author = {Jensen, Niklas S and Wehland, Markus and Wise, Petra M and Grimm, Daniela},
title = {Latest Knowledge on the Role of Vitamin D in Hypertension},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24054679}
}
EUVIMED